Cephalexin

Product NDC: 0093-3145
Requested package NDC: 0093-3145-01
11-digit product format: 000933145
Labeler code: 0093
Product ID: 0093-3145_c75c0bb6-fe3e-43c6-bdde-edd904731795
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cephalexin
Dosage form: CAPSULE
Route: ORAL
Labeler: Teva Pharmaceuticals USA, Inc.
Application: ANDA062702
Marketing category: ANDA
Marketing start: 1990-09-30
Substance: CEPHALEXIN
Active strength: 250 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0093-3145	0093-3145-01	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062702-001	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB		1987-02-13
A062702-002	CEPHALEXIN	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB		1987-02-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A062702-001	AB
A062702-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A062702-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1987-02-13	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A062702-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1987-02-13	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A062702-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A062702-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A062702-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062702-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062702-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062702-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062702-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062702-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062702-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062702-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062702-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062702-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062702-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062702-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062702-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062702-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062702-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062702-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062702-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062702-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062702-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062702-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062702-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062702-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062702-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062702-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062702-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062702-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062702-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062702-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062702-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062702-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A062702-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A062702-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A062702-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A062702-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A062702-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062702-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A062702-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A062702-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cephalexin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEPHALEXIN	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
OBN7UDS42Y	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309110	Internal RxNorm lookup
309112	Internal RxNorm lookup
309113	Internal RxNorm lookup
309114	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
19307ff0-71de-477b-965d-ea243e5ede3a	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508
9869efd7-d6dd-0665-5b67-53adbe6ef15e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0093-3145-01	Cephalexin	100 in 1 BOTTLE	CAPSULE	100		26
0093-3145-05	Cephalexin	500 in 1 BOTTLE	CAPSULE	500		26

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0093-3145-01	EA - Each	0093-3145	02833a03-d90f-4542-b7d4-9e249a14b46c	1	2012-07-24
0093-3145-05	EA - Each	0093-3145	344dac07-20ce-42b7-a00f-785abc63c98d	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
HYPROMELLOSE 2910 (3 MPA.S)	INACTIVE INGREDIENT	0VUT3PMY82	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC]	13
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
CEPHALEXIN	ACTIVE MOIETY	OBN7UDS42Y	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.]	9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0093-3145	CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA, INC.]	26	Current NDC, Legacy NDC, 2 package rows	20220316_19307ff0-71de-477b-965d-ea243e5ede3a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cephalexin	CEPHALEXIN	REMEDYREPACK INC.	b73593ce-0b1f-4371-bae1-140742de3b42	2026-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	Unit Dose Solutions, Inc.	53704ffd-b4f6-8b61-e063-6394a90a01f9	2026-06-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	Preferred Pharmaceuticals Inc.	ad676021-44f3-4a97-a3dc-28a62fe982bb	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	PD-Rx Pharmaceuticals, Inc.	3fed2817-fc0d-43cd-9f02-948fbc76672c	2026-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	AVKARE	74f83298-57f7-4166-8dd8-db3e556a68d8	2025-12-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	QPharma Inc	e8b3ece4-cf73-416c-8767-68f425df35f8	2025-12-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	QPharma Inc	4e9a8ed3-c490-4a0e-bb29-5eea506f893b	2025-12-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	PD-Rx Pharmaceuticals, Inc.	6ce11859-aa21-4b3f-bd59-3cd26deca82b	2025-11-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	A-S Medication Solutions	bff3912c-c39c-40c0-98d2-27c3d506c24d	2025-10-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals,Inc.	ade02343-3e4b-b1f1-e053-2995a90ac5fe	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	A-S Medication Solutions	fc426d0d-9774-4189-8d83-89aa85d926bb	2024-05-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	A-S Medication Solutions	5b7666f3-4014-45ce-8387-3298d9fe6d25	2024-05-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	18518154-30ba-48a4-852a-3a7723030071	2023-12-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	Proficient Rx LP	ada7b8a5-98f4-454c-b38f-92192d4db33f	2021-08-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702
Cephalexin	CEPHALEXIN	Teva Pharmaceuticals USA, Inc.	19307ff0-71de-477b-965d-ea243e5ede3a	2020-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062702 application number: ANDA062702 ndc (package): 0093-3145-01 ndc (product): 0093-3145 ndc11 (package): 00093314501

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309112	cephalexin 250 MG Oral Capsule	PSN	3fed2817-fc0d-43cd-9f02-948fbc76672c	27
309112	cephalexin 250 MG Oral Capsule	SCD	3fed2817-fc0d-43cd-9f02-948fbc76672c	27
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	3fed2817-fc0d-43cd-9f02-948fbc76672c	27
309110	cephalexin 125 MG in 5 mL Oral Suspension	PSN	19307ff0-71de-477b-965d-ea243e5ede3a	26
309113	cephalexin 250 MG in 5 mL Oral Suspension	PSN	19307ff0-71de-477b-965d-ea243e5ede3a	26
309112	cephalexin 250 MG Oral Capsule	PSN	19307ff0-71de-477b-965d-ea243e5ede3a	26
309114	cephalexin 500 MG Oral Capsule	PSN	19307ff0-71de-477b-965d-ea243e5ede3a	26
309110	cephalexin 25 MG/ML Oral Suspension	SCD	19307ff0-71de-477b-965d-ea243e5ede3a	26
309112	cephalexin 250 MG Oral Capsule	SCD	19307ff0-71de-477b-965d-ea243e5ede3a	26
309113	cephalexin 50 MG/ML Oral Suspension	SCD	19307ff0-71de-477b-965d-ea243e5ede3a	26
309114	cephalexin 500 MG Oral Capsule	SCD	19307ff0-71de-477b-965d-ea243e5ede3a	26
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	19307ff0-71de-477b-965d-ea243e5ede3a	26
309110	cefalexin 25 MG/ML Oral Suspension	SY	19307ff0-71de-477b-965d-ea243e5ede3a	26
309113	cefalexin 50 MG/ML Oral Suspension	SY	19307ff0-71de-477b-965d-ea243e5ede3a	26
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	19307ff0-71de-477b-965d-ea243e5ede3a	26
309110	cephalexin 125 MG per 5 ML Oral Suspension	SY	19307ff0-71de-477b-965d-ea243e5ede3a	26
309113	cephalexin 250 MG per 5 ML Oral Suspension	SY	19307ff0-71de-477b-965d-ea243e5ede3a	26
309112	cephalexin 250 MG Oral Capsule	PSN	4e9a8ed3-c490-4a0e-bb29-5eea506f893b	5
309112	cephalexin 250 MG Oral Capsule	SCD	4e9a8ed3-c490-4a0e-bb29-5eea506f893b	5
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	4e9a8ed3-c490-4a0e-bb29-5eea506f893b	5
309112	cephalexin 250 MG Oral Capsule	PSN	eea0596f-26e4-4002-8bda-980890991c15	2
309112	cephalexin 250 MG Oral Capsule	SCD	eea0596f-26e4-4002-8bda-980890991c15	2
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	eea0596f-26e4-4002-8bda-980890991c15	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0093-3145-01	00093314501	100 CAPSULE in 1 BOTTLE (0093-3145-01)	100 capsule	1990-09-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cephalexin	PD-Rx Pharmaceuticals, Inc.	2026-03-18	HUMAN PRESCRIPTION DRUG LABEL	27
Cephalexin	QPharma Inc \| Teva Pharmaceuticals USA, Inc.	2025-12-04	HUMAN PRESCRIPTION DRUG LABEL	5
Cephalexin	REMEDYREPACK INC.	2024-01-15	HUMAN PRESCRIPTION DRUG LABEL	2
Cephalexin	Teva Pharmaceuticals USA, Inc.	2020-12-31	HUMAN PRESCRIPTION DRUG LABEL	26
Cephalexin	Aidarex Pharmaceuticals LLC	2017-05-18	HUMAN PRESCRIPTION DRUG LABEL	2